ARCHIVES

FDA, NCI, CMS Announce Biomarker Initiative; First Project To Validate FDG-PET As Predictor Of Tumor Response In Non-Hodgkin’s Lymphoma.

This article is from The Cancer Letter archive.

Vol. 32 No. 06 | February 17, 2006

Download PDF Visit The Full Archive

Related Articles

American Cancer Society Awards its Medal of Honor

May 24, 2013

NCI-Approved CTEP Trials For The Month of July

July 27, 2012

DCE Board Approves Recompetition Of Large Support Contracts

March 16, 1990

Komen Foundation Grant Recipients Are Listed

August 13, 1993

ODAC Votes Against Cell Therapeutics Agent; Requires ChemGenex To Develop Diagnostic.

April 9, 2010

Cancer Vaccine RFAs Approved In Concept By NCI Advisors

July 26, 1991